nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednicarbate—Dermatitis acneiform—Erlotinib—lung cancer	0.0504	0.0686	CcSEcCtD
Prednicarbate—Eruption—Gefitinib—lung cancer	0.0469	0.0638	CcSEcCtD
Prednicarbate—Folliculitis—Erlotinib—lung cancer	0.0274	0.0373	CcSEcCtD
Prednicarbate—Telangiectasia—Methotrexate—lung cancer	0.026	0.0354	CcSEcCtD
Prednicarbate—Amcinonide—ANXA1—lung cancer	0.0203	0.305	CrCbGaD
Prednicarbate—Eruption—Gemcitabine—lung cancer	0.0195	0.0265	CcSEcCtD
Prednicarbate—Secondary infection—Doxorubicin—lung cancer	0.018	0.0245	CcSEcCtD
Prednicarbate—Folliculitis—Paclitaxel—lung cancer	0.0159	0.0217	CcSEcCtD
Prednicarbate—Leukoderma—Methotrexate—lung cancer	0.0144	0.0196	CcSEcCtD
Prednicarbate—Eruption—Docetaxel—lung cancer	0.0138	0.0188	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—BPTF—lung cancer	0.0137	0.069	CbGpPWpGaD
Prednicarbate—Leukoderma—Doxorubicin—lung cancer	0.0125	0.017	CcSEcCtD
Prednicarbate—Oedema—Crizotinib—lung cancer	0.0113	0.0154	CcSEcCtD
Prednicarbate—Infection—Crizotinib—lung cancer	0.0113	0.0153	CcSEcCtD
Prednicarbate—Oedema—Pemetrexed—lung cancer	0.0104	0.0141	CcSEcCtD
Prednicarbate—Infection—Pemetrexed—lung cancer	0.0103	0.014	CcSEcCtD
Prednicarbate—Infection—Gefitinib—lung cancer	0.0102	0.0139	CcSEcCtD
Prednicarbate—Paraesthesia—Crizotinib—lung cancer	0.0102	0.0138	CcSEcCtD
Prednicarbate—Eruption—Methotrexate—lung cancer	0.00995	0.0135	CcSEcCtD
Prednicarbate—Folliculitis—Methotrexate—lung cancer	0.00974	0.0133	CcSEcCtD
Prednicarbate—Pain—Pemetrexed—lung cancer	0.00885	0.012	CcSEcCtD
Prednicarbate—Pain—Gefitinib—lung cancer	0.0088	0.012	CcSEcCtD
Prednicarbate—Eruption—Doxorubicin—lung cancer	0.00862	0.0117	CcSEcCtD
Prednicarbate—Hydrocortisone—ANXA1—lung cancer	0.00857	0.129	CrCbGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—lung cancer	0.00845	0.0426	CbGpPWpGaD
Prednicarbate—Folliculitis—Doxorubicin—lung cancer	0.00843	0.0115	CcSEcCtD
Prednicarbate—Oedema—Teniposide—lung cancer	0.00838	0.0114	CcSEcCtD
Prednicarbate—Infection—Teniposide—lung cancer	0.00833	0.0113	CcSEcCtD
Prednicarbate—Urticaria—Pemetrexed—lung cancer	0.00822	0.0112	CcSEcCtD
Prednicarbate—Urticaria—Gefitinib—lung cancer	0.00817	0.0111	CcSEcCtD
Prednicarbate—Pruritus—Pemetrexed—lung cancer	0.00732	0.00996	CcSEcCtD
Prednicarbate—Pruritus—Gefitinib—lung cancer	0.00728	0.0099	CcSEcCtD
Prednicarbate—Rash—Crizotinib—lung cancer	0.00714	0.00972	CcSEcCtD
Prednicarbate—Dermatitis—Crizotinib—lung cancer	0.00714	0.00971	CcSEcCtD
Prednicarbate—Urticaria—Teniposide—lung cancer	0.00666	0.00906	CcSEcCtD
Prednicarbate—Rash—Pemetrexed—lung cancer	0.00653	0.00888	CcSEcCtD
Prednicarbate—Dermatitis—Pemetrexed—lung cancer	0.00652	0.00887	CcSEcCtD
Prednicarbate—Rash—Gefitinib—lung cancer	0.00648	0.00882	CcSEcCtD
Prednicarbate—Dermatitis—Gefitinib—lung cancer	0.00648	0.00882	CcSEcCtD
Prednicarbate—Dexamethasone—ANXA1—lung cancer	0.00639	0.0958	CrCbGaD
Prednicarbate—NR3C1—Nuclear Receptors—RARB—lung cancer	0.00628	0.0317	CbGpPWpGaD
Prednicarbate—Infection—Topotecan—lung cancer	0.00617	0.0084	CcSEcCtD
Prednicarbate—Oedema—Erlotinib—lung cancer	0.00615	0.00837	CcSEcCtD
Prednicarbate—Infection—Erlotinib—lung cancer	0.00611	0.00831	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—NKX2-1—lung cancer	0.00596	0.0301	CbGpPWpGaD
Prednicarbate—Pruritus—Teniposide—lung cancer	0.00593	0.00807	CcSEcCtD
Prednicarbate—Paraesthesia—Vinblastine—lung cancer	0.00574	0.00782	CcSEcCtD
Prednicarbate—Paraesthesia—Topotecan—lung cancer	0.00558	0.00759	CcSEcCtD
Prednicarbate—Pain—Vinblastine—lung cancer	0.00547	0.00744	CcSEcCtD
Prednicarbate—Pain—Topotecan—lung cancer	0.00531	0.00723	CcSEcCtD
Prednicarbate—Rash—Teniposide—lung cancer	0.00529	0.00719	CcSEcCtD
Prednicarbate—Dermatitis—Teniposide—lung cancer	0.00528	0.00719	CcSEcCtD
Prednicarbate—Infection—Vinorelbine—lung cancer	0.00528	0.00719	CcSEcCtD
Prednicarbate—Pain—Erlotinib—lung cancer	0.00526	0.00715	CcSEcCtD
Prednicarbate—Dermatitis contact—Doxorubicin—lung cancer	0.00524	0.00713	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—NODAL—lung cancer	0.00507	0.0256	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—RARB—lung cancer	0.00496	0.025	CbGpPWpGaD
Prednicarbate—Urticaria—Topotecan—lung cancer	0.00494	0.00672	CcSEcCtD
Prednicarbate—Paraesthesia—Vinorelbine—lung cancer	0.00477	0.0065	CcSEcCtD
Prednicarbate—Pain—Vinorelbine—lung cancer	0.00455	0.00619	CcSEcCtD
Prednicarbate—Pruritus—Topotecan—lung cancer	0.0044	0.00598	CcSEcCtD
Prednicarbate—Oedema—Irinotecan—lung cancer	0.00438	0.00597	CcSEcCtD
Prednicarbate—Infection—Irinotecan—lung cancer	0.00436	0.00593	CcSEcCtD
Prednicarbate—Pruritus—Erlotinib—lung cancer	0.00435	0.00592	CcSEcCtD
Prednicarbate—Oedema—Gemcitabine—lung cancer	0.00427	0.00581	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—lung cancer	0.00427	0.0215	CbGpPWpGaD
Prednicarbate—Infection—Gemcitabine—lung cancer	0.00424	0.00577	CcSEcCtD
Prednicarbate—Urticaria—Vinorelbine—lung cancer	0.00422	0.00575	CcSEcCtD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—lung cancer	0.00412	0.0208	CbGpPWpGaD
Prednicarbate—Oedema—Cisplatin—lung cancer	0.00398	0.00542	CcSEcCtD
Prednicarbate—Infection—Cisplatin—lung cancer	0.00395	0.00538	CcSEcCtD
Prednicarbate—Paraesthesia—Irinotecan—lung cancer	0.00394	0.00536	CcSEcCtD
Prednicarbate—Rash—Topotecan—lung cancer	0.00392	0.00533	CcSEcCtD
Prednicarbate—Dermatitis—Topotecan—lung cancer	0.00391	0.00533	CcSEcCtD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—lung cancer	0.00388	0.0196	CbGpPWpGaD
Prednicarbate—Rash—Erlotinib—lung cancer	0.00388	0.00528	CcSEcCtD
Prednicarbate—Dermatitis—Erlotinib—lung cancer	0.00387	0.00527	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—SOX2—lung cancer	0.00384	0.0194	CbGpPWpGaD
Prednicarbate—Paraesthesia—Gemcitabine—lung cancer	0.00383	0.00522	CcSEcCtD
Prednicarbate—Pruritus—Vinorelbine—lung cancer	0.00376	0.00512	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—NPPA—lung cancer	0.00375	0.0189	CbGpPWpGaD
Prednicarbate—Pain—Irinotecan—lung cancer	0.00375	0.0051	CcSEcCtD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—lung cancer	0.00369	0.0186	CbGpPWpGaD
Prednicarbate—Clobetasol propionate—CYP1A1—lung cancer	0.00367	0.055	CrCbGaD
Prednicarbate—Pain—Gemcitabine—lung cancer	0.00365	0.00497	CcSEcCtD
Prednicarbate—Infection—Etoposide—lung cancer	0.00362	0.00493	CcSEcCtD
Prednicarbate—Oedema—Paclitaxel—lung cancer	0.00358	0.00487	CcSEcCtD
Prednicarbate—Paraesthesia—Cisplatin—lung cancer	0.00357	0.00486	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—ATF3—lung cancer	0.00356	0.0179	CbGpPWpGaD
Prednicarbate—Infection—Paclitaxel—lung cancer	0.00355	0.00483	CcSEcCtD
Prednicarbate—Prednisolone—CYP2A6—lung cancer	0.00344	0.0516	CrCbGaD
Prednicarbate—Pain—Cisplatin—lung cancer	0.0034	0.00463	CcSEcCtD
Prednicarbate—Rash—Vinorelbine—lung cancer	0.00335	0.00456	CcSEcCtD
Prednicarbate—Dermatitis—Vinorelbine—lung cancer	0.00335	0.00456	CcSEcCtD
Prednicarbate—Paraesthesia—Etoposide—lung cancer	0.00327	0.00446	CcSEcCtD
Prednicarbate—NR3C1—Endoderm Differentiation—PTHLH—lung cancer	0.00327	0.0165	CbGpPWpGaD
Prednicarbate—Paraesthesia—Paclitaxel—lung cancer	0.00321	0.00437	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—SFN—lung cancer	0.0032	0.0161	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—lung cancer	0.00316	0.0159	CbGpPWpGaD
Prednicarbate—Pain—Etoposide—lung cancer	0.00312	0.00424	CcSEcCtD
Prednicarbate—Pain—Paclitaxel—lung cancer	0.00306	0.00416	CcSEcCtD
Prednicarbate—Oedema—Docetaxel—lung cancer	0.00303	0.00412	CcSEcCtD
Prednicarbate—Pruritus—Gemcitabine—lung cancer	0.00302	0.00411	CcSEcCtD
Prednicarbate—Infection—Docetaxel—lung cancer	0.00301	0.0041	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—lung cancer	0.00295	0.0149	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—APP—lung cancer	0.00291	0.0147	CbGpPWpGaD
Prednicarbate—Urticaria—Etoposide—lung cancer	0.0029	0.00394	CcSEcCtD
Prednicarbate—Urticaria—Paclitaxel—lung cancer	0.00284	0.00387	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00281	0.0141	CbGpPWpGaD
Prednicarbate—Rash—Irinotecan—lung cancer	0.00276	0.00376	CcSEcCtD
Prednicarbate—Dermatitis—Irinotecan—lung cancer	0.00276	0.00376	CcSEcCtD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IRF1—lung cancer	0.00275	0.0139	CbGpPWpGaD
Prednicarbate—Paraesthesia—Docetaxel—lung cancer	0.00272	0.0037	CcSEcCtD
Prednicarbate—NR3C1—AP-1 transcription factor network—JUNB—lung cancer	0.00269	0.0136	CbGpPWpGaD
Prednicarbate—Rash—Gemcitabine—lung cancer	0.00269	0.00366	CcSEcCtD
Prednicarbate—Dermatitis—Gemcitabine—lung cancer	0.00269	0.00366	CcSEcCtD
Prednicarbate—NR3C1—Circadian Clock—AVP—lung cancer	0.00268	0.0135	CbGpPWpGaD
Prednicarbate—Pain—Docetaxel—lung cancer	0.00259	0.00353	CcSEcCtD
Prednicarbate—Pruritus—Etoposide—lung cancer	0.00258	0.00351	CcSEcCtD
Prednicarbate—Pruritus—Paclitaxel—lung cancer	0.00253	0.00344	CcSEcCtD
Prednicarbate—Rash—Cisplatin—lung cancer	0.00251	0.00342	CcSEcCtD
Prednicarbate—Dermatitis—Cisplatin—lung cancer	0.00251	0.00341	CcSEcCtD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—lung cancer	0.00248	0.0125	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.00245	0.0124	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—lung cancer	0.00239	0.012	CbGpPWpGaD
Prednicarbate—Megestrol acetate—ABCB1—lung cancer	0.00237	0.0356	CrCbGaD
Prednicarbate—Hydrocortisone—ABCG2—lung cancer	0.00235	0.0353	CrCbGaD
Prednicarbate—NR3C1—Adipogenesis—AHR—lung cancer	0.00235	0.0118	CbGpPWpGaD
Prednicarbate—Rash—Etoposide—lung cancer	0.0023	0.00313	CcSEcCtD
Prednicarbate—Dermatitis—Etoposide—lung cancer	0.0023	0.00313	CcSEcCtD
Prednicarbate—Rash—Paclitaxel—lung cancer	0.00225	0.00307	CcSEcCtD
Prednicarbate—Dermatitis—Paclitaxel—lung cancer	0.00225	0.00306	CcSEcCtD
Prednicarbate—Infection—Methotrexate—lung cancer	0.00217	0.00295	CcSEcCtD
Prednicarbate—Pruritus—Docetaxel—lung cancer	0.00214	0.00292	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.00213	0.0107	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—HIF1A—lung cancer	0.00213	0.0107	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—lung cancer	0.0021	0.0106	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL10—lung cancer	0.00208	0.0105	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.00198	0.00997	CbGpPWpGaD
Prednicarbate—Paraesthesia—Methotrexate—lung cancer	0.00196	0.00267	CcSEcCtD
Prednicarbate—Dexamethasone—CYP2A6—lung cancer	0.00196	0.0294	CrCbGaD
Prednicarbate—NR3C1—Adipogenesis—LMNA—lung cancer	0.00195	0.00981	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.00194	0.0098	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.00192	0.00965	CbGpPWpGaD
Prednicarbate—Rash—Docetaxel—lung cancer	0.00191	0.0026	CcSEcCtD
Prednicarbate—Dermatitis—Docetaxel—lung cancer	0.00191	0.0026	CcSEcCtD
Prednicarbate—Oedema—Doxorubicin—lung cancer	0.00189	0.00257	CcSEcCtD
Prednicarbate—Infection—Doxorubicin—lung cancer	0.00188	0.00256	CcSEcCtD
Prednicarbate—Pain—Methotrexate—lung cancer	0.00187	0.00254	CcSEcCtD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—lung cancer	0.00185	0.00933	CbGpPWpGaD
Prednicarbate—Methylprednisolone—ABCB1—lung cancer	0.00182	0.0273	CrCbGaD
Prednicarbate—Triamcinolone—PTGS2—lung cancer	0.0018	0.027	CrCbGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.00179	0.00902	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.00177	0.00892	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.00175	0.00884	CbGpPWpGaD
Prednicarbate—Dexamethasone—ABCG2—lung cancer	0.00175	0.0263	CrCbGaD
Prednicarbate—NR3C1—Circadian Clock—CREBBP—lung cancer	0.00174	0.00875	CbGpPWpGaD
Prednicarbate—Urticaria—Methotrexate—lung cancer	0.00174	0.00236	CcSEcCtD
Prednicarbate—Paraesthesia—Doxorubicin—lung cancer	0.0017	0.00231	CcSEcCtD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.00168	0.00847	CbGpPWpGaD
Prednicarbate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.00162	0.00819	CbGpPWpGaD
Prednicarbate—Pain—Doxorubicin—lung cancer	0.00162	0.0022	CcSEcCtD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.00161	0.00813	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—APC—lung cancer	0.00158	0.00797	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.00156	0.00786	CbGpPWpGaD
Prednicarbate—Pruritus—Methotrexate—lung cancer	0.00155	0.0021	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.00152	0.00766	CbGpPWpGaD
Prednicarbate—Urticaria—Doxorubicin—lung cancer	0.0015	0.00204	CcSEcCtD
Prednicarbate—Betamethasone—PTGS2—lung cancer	0.00148	0.0221	CrCbGaD
Prednicarbate—Prednisone—ALB—lung cancer	0.00146	0.0218	CrCbGaD
Prednicarbate—Dexamethasone—CYP2E1—lung cancer	0.00139	0.0209	CrCbGaD
Prednicarbate—Prednisone—ABCB1—lung cancer	0.00139	0.0208	CrCbGaD
Prednicarbate—Rash—Methotrexate—lung cancer	0.00138	0.00187	CcSEcCtD
Prednicarbate—Dermatitis—Methotrexate—lung cancer	0.00138	0.00187	CcSEcCtD
Prednicarbate—Dexamethasone—CYP1A1—lung cancer	0.00137	0.0206	CrCbGaD
Prednicarbate—Pruritus—Doxorubicin—lung cancer	0.00134	0.00182	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.00132	0.00666	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.0013	0.00653	CbGpPWpGaD
Prednicarbate—Prednisolone—ABCB1—lung cancer	0.00128	0.0192	CrCbGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.00127	0.00642	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.00126	0.00636	CbGpPWpGaD
Prednicarbate—Betamethasone—ABCB1—lung cancer	0.00125	0.0188	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.00125	0.00632	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.00122	0.00614	CbGpPWpGaD
Prednicarbate—Rash—Doxorubicin—lung cancer	0.00119	0.00162	CcSEcCtD
Prednicarbate—Dermatitis—Doxorubicin—lung cancer	0.00119	0.00162	CcSEcCtD
Prednicarbate—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.00119	0.00597	CbGpPWpGaD
Prednicarbate—NR3C1—Circadian Clock—EP300—lung cancer	0.00118	0.00596	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.00117	0.00587	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.00114	0.00573	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.0011	0.00555	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.0011	0.00552	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.00109	0.00548	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.00107	0.0054	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—HIF1A—lung cancer	0.00107	0.00539	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.00107	0.00538	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.00106	0.00534	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.00106	0.00533	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.00103	0.00519	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.00102	0.00516	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.001	0.00505	CbGpPWpGaD
Prednicarbate—Hydrocortisone—ABCB1—lung cancer	0.000979	0.0147	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000975	0.00492	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000958	0.00483	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000941	0.00474	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000932	0.0047	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000924	0.00466	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000924	0.00465	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000912	0.0046	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000903	0.00455	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—RB1—lung cancer	0.00087	0.00438	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000868	0.00437	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000859	0.00433	CbGpPWpGaD
Prednicarbate—Dexamethasone—PTGS2—lung cancer	0.000858	0.0129	CrCbGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000857	0.00432	CbGpPWpGaD
Prednicarbate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000855	0.00431	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.00085	0.00428	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000835	0.00421	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000824	0.00415	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.00077	0.00388	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000756	0.00381	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000756	0.00381	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000754	0.0038	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—KHSRP—lung cancer	0.000753	0.0038	CbGpPWpGaD
Prednicarbate—Dexamethasone—ABCB1—lung cancer	0.00073	0.0109	CrCbGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000698	0.00352	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000658	0.00332	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.000639	0.00322	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000633	0.00319	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000625	0.00315	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.000615	0.0031	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.0006	0.00302	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000599	0.00302	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—DICER1—lung cancer	0.000595	0.003	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000573	0.00289	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.000563	0.00284	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—STAT3—lung cancer	0.000557	0.00281	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000557	0.00281	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000525	0.00264	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.000519	0.00262	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—SKI—lung cancer	0.000514	0.00259	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000514	0.00259	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000487	0.00245	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—RARB—lung cancer	0.000413	0.00208	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NPPA—lung cancer	0.000402	0.00203	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—IL6—lung cancer	0.000389	0.00196	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—HSPB1—lung cancer	0.000346	0.00174	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000337	0.0017	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	0.000319	0.00161	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—NOTCH3—lung cancer	0.000305	0.00154	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—JUNB—lung cancer	0.000289	0.00145	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ERCC2—lung cancer	0.00021	0.00106	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—MYC—lung cancer	0.000189	0.000953	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—CREBBP—lung cancer	0.000153	0.000773	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MAPK3—lung cancer	9.36e-05	0.000472	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MYC—lung cancer	9.11e-05	0.000459	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—AKT1—lung cancer	6.32e-05	0.000318	CbGpPWpGaD
